Article
Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung…
medRxiv · 2024 · Anastasiou, P.; Moore, C.; Rana, S.; de Castro, A.; Tomaschko, M.; Boumelha, J.; Mugarza, E.; Blaj, C.; de Carne Trecesson, S.; Goldstone, R.; Smith, J.; Quintana, E.; Molina-Arcas, M.; Downward, J.
Key facts
| Title | Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold tumours hot |
|---|---|
| First author | Anastasiou, P.; Moore, C.; Rana, S.; de Castro, A.; Tomaschko, M.; Boumelha, J.; Mugarza, E.; Blaj, C.; de Carne Trecesson, S.; Goldstone, R.; Smith, J.; Quintana, E.; Molina-Arcas, M.; Downward, J. |
| Journal | medRxiv |
| Published | Jan 17, 2024 |
| DOI | 10.1101/2024.01.15.575765 |
| Devices mentioned | BK110039, K103302 |
| Product codes mentioned | JJH, KIT, MVU, NDS, NJT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1